A Prospective Multicenter Phase 2 Study of Dose-Adjusted-EPOCH-R in Untreated MYC-Rearranged Aggressive B-cell Lymphoma

Por Dunleavy, Kieron, Fanale, Michelle A., Abramson, Jeremy S., Noy, Ariela, Caimi, Paolo Fabrizio, Pittaluga, Stefania, Parekh, Samir, Lacasce, Ann, Hayslip, John W, Jagadeesh, Deepa, Nagpal, Sunil, Lechowicz, Mary Jo, Gaur, Rakesh, Lucas, Andrea, Melani, Christopher, Roschewski, Mark, Steinberg, Seth M., Jaffe, Elaine S., Kahl, Brad, Friedberg, Jonathan W., Little, Richard F., Bartlett, Nancy L., Wilson, Wyndham H.
Publicado no Lancet Haematol (2018)

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

Por Gibson, Christopher J., Lindsley, R. Coleman, Tchekmedyian, Vatche, Mar, Brenton G., Shi, Jiantao, Jaiswal, Siddhartha, Bosworth, Alysia, Francisco, Liton, He, Jianbo, Bansal, Anita, Morgan, Elizabeth A., Lacasce, Ann S., Freedman, Arnold S., Fisher, David C., Jacobsen, Eric, Armand, Philippe, Alyea, Edwin P., Koreth, John, Ho, Vincent, Soiffer, Robert J., Antin, Joseph H., Ritz, Jerome, Nikiforow, Sarah, Forman, Stephen J., Michor, Franziska, Neuberg, Donna, Bhatia, Ravi, Bhatia, Smita, Ebert, Benjamin L.
Publicado no J Clin Oncol (2017)